Transplantation of hematopoietic stem cells from the peripheral blood

Journal of Cellular and Molecular Medicine

Volumn 9, Issue 1, 2005, Pages 37-50

  Jansen, Jan ^a   Hanks, Susan ^a   Thompson, James M ^a   Dugan, Michael J ^a   Akard, Luke P ^a  

^a Indiana Blood and Marrow Transplantation   (United States)

Author keywords

Bone marrow; CD34; CFU GM; Colony forming unit granulocyte macrophage; Hematopoietic stem cells; Mobilization; Peripheral blood stem cells; Stem cell transplantation

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL; BONE MARROW TRANSPLANTATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY; HUMAN; METHODOLOGY; NEOPLASM; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REVIEW; STEM CELL MOBILIZATION;

ANIMALS; BONE MARROW TRANSPLANTATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

EID: 17144411879     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2005.tb00335.x     Document Type: Review

References (63)

1. Doss M.X., Koehler C.I., Gissel C., Hescheler J., Sachinidis A., Embryonic stem cells: a promising tool for cell replacement therapy, J. Cell. Mol. Med., 8:465-473, 2004
2. Wakayama T., Tabar V., Rodigues I., Perry A.C.F., Studer L., Mombaerts P., Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer, Science, 292: 740-744, 2001
3. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., Itescu S., Neovascularization of ischemic myocardium by human bone-marrow derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function, Nature Medicine, 7: 430-436, 2001
4. Petersen B.E., Bowen W.C., Patrene K.D., Mars W.M., Sullivan A.K., Murase N., Boggs S.S., Greenberger J.S., Goff J.P., Bone marrow as a potential source of hepatic oval cells, Science, 284: 1168-1170, 1999
5. Maximow A., Der Lymphozyt als gemeinsame Stammzelle der verschiedene Blutelemente in der embryonalen Entwicklung und im postfetalen Leben der Saugetiere, Folia Haematol. (Leipzig), 8; 125-141, 1909
6. Santos G.W., History of bone marrow transplantation, Clin. Haematol., 12: 611-639, 1983
7. Jacobsen L.O., Marks E.K., Gaston E.O., Effect of spleen protection on mortality following x-irradiation, J. Lab. Clin. Med., 12: 1538-1543, 1949
8. Ford C.E., Hamerton J.L., Barnes D.W.H., Loutit J.F., Cytological identification of radiation chimera, Nature, 177: 452-454, 1956
9. Thomas E.D., Lochte H.L., Lu W.C., Ferrebee J.W., Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy, N. Engl. J. Med., 257: 491-496, 1957
10. Mathé G., Amiel J.L., Schwarzenberg L., Cattan A., Schneider M. Hemopoietic chimera in man after allogeneic (homologous) bone marrow transplantation. Control of secondary syndrome. Specific tolerance due to the chimerism, Brit. Med. J., 2: 1633-1635, 1963
11. Thomas E.D., Blume K.G. Historical markers in the development of allogeneic hematopoietic cell transplantation, Biol. Blood. Marrow. Transplant., 5: 341-346, 1999
12. Micklem H.S., Anderson N., Ross E., Limited potential of circulating hematopoietic stem cells, Nature, 256: 41-43, 1975
13. Chervenick P.A., Boggs D.R., In vitro growth of granulocytic mononuclear cell colonies from blood of normal individuals, Blood, 37: 131-138, 1971
14. Zwaan F.E., Haematopoietic progenitor cells in the peripheral blood, Blut, 45: 87-95, 1982
15. Bekkum D.W. van, Noord M.J. van, Maat B., Dicke K.A., Attempts at identification of hemopoietic stem cell in mouse, Blood, 38: 547-558, 1971
16. Krauss D.S., Fackler M.J., Civin C.I., May W.S., CD34: structure, biology, and clinical utility, Blood, 87: 1-13, 1996
17. Calvo W., Fliedner T.M., Herbst E., Regeneration of blood forming organs after autologous leukocyte transfusion in lethally irradiated dogs. II. Distribution and cellularity of the marrow in irradiated and transfused animals. Blood, 47: 593-601, 1976
18. Kessinger A., Smith D.M., Strandjord S.F., Landmark J.D., Dooley DC, Law P, Coccia PF, Weisenberger DD, Armitage JO. Allogeneic transplantation of blood-derived, T-cell depleted hematopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia, Bone Marrow Transplant, 4: 643-646, 1989
19. Sheridan W.P., Begley C.G., Juttner C.A., Szer J., To L.B., Maher D., McGrath K.M., Morstyn G., Fox R.M., Effect of peripheral-blood progenitor cells mobilized ny filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy, Lancet, 339: 640-644, 1992
20. Richman C.M., Weiner R.S., Yankee R.A., Increase in circulating stem cells following chemotherapy in man, Blood, 47: 1031-1034, 1976
21. To L.B., Haylock D.N., Simmons P.J., Juttner C.A., The biology and clinical uses of blood stem cells, Blood, 89: 2233-2258, 1997
22. Körbling M., Fliedner T.M., The evolution of clinical peripheral blood stem cell transplantation, Bone Marrow Transplant, 7: 675-678, 1996
23. Gillespie T.W., Hillyer C.D., Peripheral blood progenitor cells for marrow reconstitution: mobilization and collection strategies, Transfusion, 36: 611-624, 1996
24. Jansen J., Thompson J.M., Dugan M.J., Nolan P., Wiemann M., Birhiray R., Henslee-Downey P.J., Akard L.P., Peripheral blood progenitor cell transplantation, Therapeutic Apheresis, 6: 5-14, 2002
25. Körbling M., Anderlini P., Peripheral blood stem cells versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?, Blood, 98: 2900-2908, 2001
26. Siena S., Schiavo R., Pedrazzali P., Carlo-Stella C., Therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy, J. Clin. Oncol., 18: 1360-1377, 2000
27. Tricot G., Jagannath S., Vesole D., Nelson J., Tindle S., Miller L., Cheon B., Crowley J., Barlogie B., Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients, Blood, 85: 588-596, 1995
28. Weaver C.H., Potz J., Redmond J., Tauer K., Schwartzberg I.S., Kaywin P., Drapkin R., Grant B., Unger P., Allen C., Zhen B., Hazelton B., Buckner C.D., Engraftment and outcome of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell count, Bone Marrow Transplant, 19: 1103-1110, 1997
29. Shpall E.J., Champlin R., Glaspy J.A., Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery, Biol Blood Marrow Transplant, 4: 84-92, 1998
30. Grigg A.P., Roberts A.W., Raunow H., Houghton S., Layton J.E., Boyd A.W., McGrath K.M., Maher D., Optimizing dose and scheduling of filgrastim (G-CSF) for mobilization and collection of peripheral blood progenitor cells in normal volunteers, Blood, 86: 4437-4446, 1995
31. Bensinger W.I., Martin P.J., Storer B., Clift R., Forman S.J., Negrin R., Kashyar A., Flowes M.E.D., Lillbey K., Chauncey T.R., Storb R., Appelbaum F.R., Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers, N. Engl. J. Med., 344: 175-181, 2001
32. Lane T.A., Law P., Maruyama M., Young D., Burgess J., Mullen M., Mealiffe M., Terstappen L.W.M.M., Hardwick A., Moubayed M., Oldham F., Corringham R.E.T., Ho A.D., Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation, Blood, 85: 275-282, 1996
33. Ho A.D., Young D., Maruyama M., Corringham R.E.T., Mason J.R., Thompson P., Grenier K., Law P., Terstappen L.W.M.M., Lane T., Pluripotent and lineage-committed CD34+ substrates in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both, Exp. Hematol., 24: 1460-1468, 1996
34. Gianni A.M., Siena S., Bregni M., Tarella C., Stern A.C., Pileri A., Bonnadonna G., Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation, Lancetii, 580-585, 1989
35. To L.B., Haylock D.N., Dyson P.G., A comparison between 4 gm/m2 and 7 gm/m2 cyclophosphamide for peripheral blood stem cell mobilization, Int. J. Cell Cloning 10 (suppl): 33-34, 1992
36. Akard L.P., Thompson J.M., Dugan M.J., Wiemann M., Greenspan A., Hanks S., Swinney M., Nyhuis A., Jansen J., Matched pair analysis of hematopoietic progenitor cell mobilization using G-CSF vs. cyclophosphamide, etoposide, and G-CSF: enhanced CD34+ collections are not necessarily cost-effective, Biol. Blood Marrow Transplant, 5: 379-385, 1999
37. Akard L.P., Wiemann M., Thompson J.M., Swinney M., Lynn K., Hanks S., Jansen J., Impaired stem-cell collection by consecutive courses of high-dose mobilizing chemotherapy using cyclophosphamide, etoposide, and G-CSF, J. Hematother, 5: 271-277, 1996
38. Jansen J., Thompson J.M., Dugan M.J., Wiemann M.C., Hanks S., Greenspan A.R., Akard L.P., Impaired PBPC collection in patients with myeloma after high-doe melphalan, Cytotherapy, 6: 498-504, 2004
39. Dugan M.J., Akard L.P., Thompson J.M., Nademanee A., Maziarz R.T., Bensinger W.I., Liesveld J., Badel K., Dehner C., Gibney C., Calandra G., Jansen J., Treatment with AMD3100 in multiple myeloma or non-Hodgkin's lymphoma patients to increase the number of peripheral blood stem cells when given with a mobilizing regimen of chemotherapy and G-CSF, Blood, 104: 782a, 2004
40. Flomenberg N., DiPersio J., Liesveld J., McCarty J., Rowley S., Vesole D., Badel K., Calandra G., AMD3100 + G-CSF hematopoietic progenitor cells (HPC) mobilization is safe, effective, and superior to mobilization with G-CSF alone, Blood, 102: 39a, 2003
41. Pecora A.L., Lazarus H.M., Jennis A.A., Prett R.A., Goldberg S.L., Rowley S.D., Cantwell S., Cooper B.W., Copelan E.A., Herzig R.H., Meagher R., Kennedy M.J., Akard L.P., Jansen J., Ross A., Prilutskaya M., Glassco J., Kahn D., Moss T.J., Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: predictors and clinical relevance, Biol. Blood Marrow Transplant, 8: 536-543, 2002
42. Storb R., Prentice R.L., Thomas E.D., Appelbaum F.R., Deeg H.J., Doney K., Fefer A., Goodell B.W., Mickelson E., Stewart P., Sullivan K.M., Witherspoom R.P., Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia, Brit. J. Haematol., 55: 573-585, 1983
43. Collins R.H., Shpilberg O., Drobyski W.R., Porter D.I., Giralt S., Champlin R., Goodman S.A., Wolff S.N., Hu W., Verfaille C., List A., Dalton W., Ognoskie N., Chtrit A., Antin J.H., Nemunaitis J., Done leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation, J. Clin. Oncol., 15: 433-444, 1997
44. Jansen J., Goselink H.M., Veenhof W.F.J., Zwaan F.E., Blotkamp C., The impact of the composition of the bone marrow graft on engraftment and graft-versus-host disease, Exp. Hematol., 11: 967-973, 1983
45. Ho V.T., Soiffer R.J., The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation, Blood, 98: 3192-3204, 2001
46. Gyger M., Stuart R.K., Perreault C., Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor, Bone Marrow Transplant, 26: 1-16, 2000
47. Brown R.A., Adkins D., Khoury H., Vij R., Goodnough L.T., Shenay S., DiPersio J.F., Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality, J. Clin. Oncol., 17: 806-812, 1999
48. Khoury I.F., Keating M., Körbling M., Przepiorka D., Anderlini P., O'Brien S., Giralt S., Ippoliti C., Van Wolff B., Gajewski J., Donato M., Claxton D., Ueno N., Andersson B., Gee A., Champlin R., Transplant lite: induction of graft-versus-malignancy using fludarabine based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies, J. Clin. Oncol., 16: 2817-2824, 1998
49. McSweeney P.A., Niederweiser D., Shizuru J.A., Sandmaier B.M., Molina A.J., Maloney D.G., Chauncey T.R., Gooley T.A., Hegenbart U., Nash R.A., Radich J., Wagner J.L., Minor S., Appelbaum F.R., Bensinger W.I., Bryant E., Lowers M.E.D., Georges G.E., Grumet F.C., Kiem H.P., Torek-Storb B., Yu C., Blume K.G., Storb R.F., Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects, Blood, 97: 3390-3400, 2001
50. Champlin R.E., Schmitz N., Horowitz M.M., Chapuis B., Chopra R., Cornelissen J.J., Gale R.P., Goldman J.M., Loberiza F.R., Hertenstain B., Klein J.P., Montserrat E., Zhang M.J., Ringden O., Tomany S.C., Rowlings P.A., Van Hoef M.E.H.M., Gratwohl A., Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation, Blood, 95: 3702-3709, 2000
51. Horan J.T., Liesveld J.L., Fernandez I.D., Lyman G.H., Phillps G.L., Lerner N.B., Fisher S.G., Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials, Bone Marrow Transplant, 32: 293-298, 2003
52. Eapen M., Horowitz M.M., Klein J.P., Champlin R.E., Loberiza Jr. F.R., Ringden O., Wagner J.E., Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: The histocompatibility and alternate stem cell source working committee of the International Bone Marrow Transplant Registry, J. Clin. Oncol., 22: 4872-4880, 2004
53. Remberger M., Ringden O., Blau I.W., Ottinger H., Kremens B., Kiehl M.G., Aschan J., Beelen D.W., Basara N., Kumlien G., Fauser A.A., Runde V., No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cell to bone marrow using unrelated donors, Blood, 98: 1739-1745, 2001
54. Aversa F., Tabilio A., Velardi A., Cunningham I., Terenzi A., Falzetti F., Ruggeri L., Barbabietola G., Aristei C., Latini P., Reisner Y., Martelli M.F., Treatment of high-risk acute leukemia with T-cell depleted stem cells from related donors with one fully mismatched HLA haplotype, N. Engl. J. Med., 339: 1186-1193, 1998
55. Hale G., Cobbold S., Novitzky N., Bunjee D., Willemze R., Prentice H.G., Milligan D., Mackinnon S., Waldmann H., Campath-1H antibodies in stem-cell transplantation, Cytotherapy, 3: 145-164, 2001
56. Peggs K.S., Thomson K., Hart D.P., Geary J., Morris E.C., Yong K., Goldstone A.H., Linch D.C., Mackinnon S., Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses, Blood, 103: 1546-1556, 2004
57. Rodenhuis S., Bontenbal M., Beex L.V.A.M., Wagstaff J., Richel D.J., Mooij M.A., Voest E.E., Hupperets P., Tinteren H. van, Peterse H.L., TenVergert E.M., De Vries G.E., High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer, N. Engl. J. Med., 349: 7-16, 2003
58. Blaise D., Bay J.O., Faucher C., Michallet M., Boiron J.M., Choufi B., Cahn J.Y., Gratecos N., Sotto J.J., François S., Fleury J., Mohty M., Chabannon C., Bilger K., Gravis G., Viret F., Braud A.C., Bardou V.J., Maraninchi D., Viens P., Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors, Blood, 103: 435-441, 2004
59. Burt R.K., Burns W.H., Marmont A.M., Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?, Blood, 99: 768-784, 2002
60. Tyndall A., Gratwohl A., Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases, Ann. Rheum. Dis., 55: 149-151, 1996
61. Lee M.S., Makkar R.R., Stem-cell transplantation in myocardial infarction: a status report, Ann. Intern. Med., 140: 729-737, 2004
62. Körbling M., Estrov Z., Adult stem cells for tissue repair - a new therapeutic concept?, N. Engl. J. Med., 349: 570-582, 2003
63. Filip S., English D., Mokrý J., Issues in stem cell plasticity, J. Cell. Mol. Med., 8: 572-577, 2004